Examining the Tumor Microenvironment and Metabolism in Ovarian Cancer

Dong-Joo (Ellen) Cheon, PhD, Assistant Professor of Regenerative and Cancer Cell Biology at Albany Medical College and the 2017 AACR Gertrude B. Elion Cancer Research Award grantee, has been working in the field of ovarian cancer her entire career.

She was first introduced to ovarian cancer research as a graduate student at The University of Texas Health Science Center at Houston when she was tasked with generating CA125 knockout mice. CA125, or cancer antigen 125, is a blood serum biomarker routinely used to diagnose and monitor ovarian cancer.

Read More

Q&A with Anil K. Sood, MD, on Ovarian Cancer Research and Treatment

On Sunday, almost 300 of the greatest minds in ovarian cancer research will come together in Pittsburgh to discuss the latest advances in the field at the American Association for Cancer Research four-day conference on Addressing Critical Questions in Ovarian Cancer Research and Treatment.

Read More

FDA Approves New PARP Inhibitor for Ovarian Cancer

Earlier this week, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic niraparib (Zejula) for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancers that are responding to platinum-based chemotherapy.

Read More